Erivedge for Locally advanced basal cell carcinoma
Quick answer: Erivedge is used for Locally advanced basal cell carcinoma as part of a hedgehog pathway inhibitor treatment regimen. Smoothened (SMO) receptor antagonist blocking Hedgehog signaling pathway The specific dosing for Locally advanced basal cell carcinoma is determined by your prescriber based on individual factors.
Why is Erivedge used for Locally advanced basal cell carcinoma?
Erivedge belongs to the Hedgehog pathway inhibitor class. Smoothened (SMO) receptor antagonist blocking Hedgehog signaling pathway This action makes it useful for treating or managing Locally advanced basal cell carcinoma in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Erivedge is the right choice for a specific patient depends on the type and severity of Locally advanced basal cell carcinoma, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Locally advanced basal cell carcinoma
Common adult dosing range: 150 mg orally once daily. The actual dose for Locally advanced basal cell carcinoma depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Erivedge medicine page.
What to expect
Erivedge treatment for Locally advanced basal cell carcinoma typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Locally advanced basal cell carcinoma
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Erivedge is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Hedgehog pathway inhibitor for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Erivedge
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Erivedge full prescribing information · All Hedgehog pathway inhibitor alternatives
Frequently asked questions
How effective is Erivedge for Locally advanced basal cell carcinoma?
Effectiveness varies by individual response, dose, and severity. Erivedge is one of several treatment options for Locally advanced basal cell carcinoma, supported by clinical evidence within the hedgehog pathway inhibitor class. Discuss expected response with your prescriber.
How long do I need to take Erivedge for Locally advanced basal cell carcinoma?
Treatment duration depends on the nature of Locally advanced basal cell carcinoma — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Erivedge when used for Locally advanced basal cell carcinoma?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Erivedge for Locally advanced basal cell carcinoma?
Yes. Multiple medicines and non-drug options exist for Locally advanced basal cell carcinoma. Alternatives within the hedgehog pathway inhibitor class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.